Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy (NCT05591118)

🧪 Interventions in This Study

• Anticoagulant Therapy (DRUG)
• Catheter-Directed Therapy (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (40 Sites)

Showing the first 25 of 40 sites.

• The University of Alabama At Birmingham — Birmingham, Alabama
• Stanford Medicine — Palo Alto, California
• UC Davis Health — Sacramento, California
• Scripps Memorial Hospital, La Jolla — San Diego, California
• The Lundquist Institute — Torrance, California
• Christiana Care — Newark, Delaware
• MedStar Health Research Institute — Washington D.C., District of Columbia
• Baptist Health Miami Cardiac & Vascular Institute — Miami, Florida
• University of South Florida/ Tampa General Hospital — Tampa, Florida
• Emory University School of Medicine — Atlanta, Georgia
• University of Chicago Medical Center — Chicago, Illinois
• Advocate Good Samaritan Hospital — Downers Grove, Illinois
• Loyola University Chicago — Maywood, Illinois
• Southern Illinois University School of Medicine — Springfield, Illinois
• University of Iowa — Iowa City, Iowa
• MaineHealth — Portland, Maine
• Boston Medical Center — Boston, Massachusetts
• Beth Israel Deaconess Medical Center — Boston, Massachusetts
• University of Michigan — Ann Arbor, Michigan
• Trinity Health - Ann Arbor Hospital — Ypsilanti, Michigan
• Washington University in St. Louis — St Louis, Missouri
• Rutgers New Jersey Medical School — Newark, New Jersey
• University of New Mexico Health Sciences Center — Albuquerque, New Mexico
• NYU Langone Health - Tisch Hospital — New York, New York
• Icahn School of Medicine at Mount Sinai — New York, New York

📞 Contact the Study Coordinator

Phone: (212) 263-0456

Email: Sunil.rao@nyulangone.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Pulmonary Embolism

• Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism — Birmingham, Alabama
• Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial — Phoenix, Arizona
• Comparing Electrical Impedance Tomography to Computed Tomographic Angiography — Loveland, Colorado
• Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE — Bay Shore, New York
• Michigan Emergency Department Improvement Collaborative (MEDIC) Alert; Pulmonary Embolism (PE) — Ann Arbor, Michigan
• Pulmonary Embolism International THrOmbolysis Study-3 — Linz,

Explore by condition: All Pulmonary Embolism clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.